|
|
|
40
|
4141G
|
APO-NAPROXEN 250MG TAB (APO/COL)
|
NAPROXEN
|
APO-NAPROXEN
|
100'S
|
A
|
10.60
|
0.11
|
TABLET
|
28
|
TAB
|
APO
|
APOTEX INC.
|
COL
|
COLLINS LTD
|
|
28080492
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
42
|
4141G
|
APO-NAPROXEN 250MG TAB (APO)
|
NAPROXEN
|
APO-NAPROXEN
|
100'S
|
A
|
20.39
|
0.20
|
TAB
|
28
|
BOTT
|
APO
|
APOTEX INC.
|
COL
|
AVENTA BARBADOS
|
|
28080492
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
40
|
4141JP
|
PRIAXEN 500MG TAB (REM/SBI) NAPROXEN
|
NAPROXEN
|
PRIAXEN
|
10x10
|
A
|
18.46
|
0.18
|
TABLET
|
28
|
TAB
|
REM
|
REMEDICA LTD
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
28080492
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
4141JP
|
PRIAXEN 500MG TAB (REM) NAPROXEN
|
NAPROXEN
|
PRIAXEN
|
10x10
|
A
|
20.5
|
0.205
|
TAB
|
28
|
BOX
|
REM
|
REMEDICA LTD
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
28080492
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
42
|
4141JP
|
PRIAXEN 500MG TAB (REM) NAPROXEN
|
NAPROXEN
|
PRIAXEN
|
10x10
|
A
|
33.54
|
0.34
|
TAB
|
28
|
BLIS
|
REM
|
REMEDICA LTD
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
28080492
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
41
|
4141JQ
|
PEROFEN 400MG TAB (REM) IBUPROFEN
|
IBUPROFEN
|
PEROFEN
|
1000'S
|
A
|
69.43
|
0.0694
|
TAB
|
120
|
BOX
|
REM
|
REMEDICA LTD
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
28080492
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
40
|
4141KJ
|
DICLOFENAC SOD 50MG TAB (HEA/RXP)
|
DICLOFENAC SODIUM
|
DICLOFENAC SOD
|
10X10
|
A
|
2.64
|
0.03
|
TABLET
|
42
|
TAB
|
HEA
|
HEALTH 2000 INC
|
RXP
|
RX PRO INC
|
|
28080492
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
40
|
4141KK
|
IBUPROFEN 400MG TAB (HEA/RXP)
|
IBUPROFEN
|
IBUPROFEN
|
10X10
|
A
|
8.97
|
0.09
|
TABLET
|
120
|
TAB
|
HEA
|
HEALTH 2000 INC
|
RXP
|
RX PRO INC
|
|
28080492
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
40
|
4141KW
|
VOLTAREN 50MG TAB (NVS/COL) DICLOFENAC SOD
|
DICLOFENAC SODIUM
|
VOLTAREN
|
100'S
|
C
|
92.31
|
0.92
|
TABLET
|
0
|
TAB
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
28080492
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
4141KW
|
VOLTAREN 50MG TAB (NVS) DICLOFENAC SOD (C)
|
DICLOFENAC SODIUM
|
VOLTAREN
|
100'S
|
C
|
92.31
|
0.9231
|
TAB
|
42
|
BOX
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
28080492
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
42
|
4141KW
|
VOLTAREN 50MG TAB (NVS) DICLOFENAC SODIUM
|
DICLOFENAC SODIUM
|
VOLTAREN
|
100'S
|
C
|
92.31
|
0.92
|
TAB
|
42
|
BLIS
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
AVENTA BARBADOS
|
|
28080492
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
40
|
4141KX
|
IBUPROFEN 400MG TAB (HEA/ATB)
|
IBUPROFEN
|
IBUPROFEN
|
10X10
|
A
|
8.97
|
0.0897
|
TABLET IMMED
|
|
|
HEA
|
HEALTH 2000 INC
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
28080492
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2022-12-07
|
2024-03-31
|
Change Local Agent
|
oral
|
6
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2022-11-25
|
|
|
|
40
|
4141LB
|
INDOMETHACIN MK 25MG CAP (BON/COL) INDOMETHAC
|
INDOMETHACIN
|
INDOMETHACIN MK
|
100'S
|
BQ
|
8.43
|
0.08
|
CAPSULE
|
0
|
CAP
|
BON
|
CORPORACION BONIMA
|
COL
|
COLLINS LTD
|
|
28080492
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
40
|
4141PQ
|
APO-IBUPROFEN 200MG TAB (APO/COL)
|
IBUPROFEN
|
APO-IBUPROFEN
|
100'S
|
A
|
11.99
|
0.12
|
TABLET
|
120
|
TAB
|
APO
|
APOTEX INC.
|
COL
|
COLLINS LTD
|
|
28080492
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
40
|
4141QF
|
ADVIL 200MG TAB (GSK/COL) IBUPROFEN
|
IBUPROFEN
|
ADVIL
|
50'S
|
C
|
12.69
|
0.25
|
TABLET
|
0
|
TAB
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
28080492
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
4141QF
|
ADVIL 200MG TAB (GSK) IBUPROFEN
|
IBUPROFEN
|
ADVIL
|
50'S
|
A
|
13.35
|
0.2669
|
TAB
|
120
|
BOX
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
28080492
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
40
|
4141QG
|
ADVIL 200MG TAB (GSK/COL) IBUPROFEN
|
IBUPROFEN
|
ADVIL
|
24'S
|
C
|
7.42
|
0.31
|
TABLET
|
0
|
TAB
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
28080492
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
4141QG
|
ADVIL 200MG TAB (GSK) IBUPROFEN (C)
|
IBUPROFEN
|
ADVIL
|
24'S
|
C
|
7.8
|
0.3251
|
TAB
|
120
|
BOX
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
28080492
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
42
|
4141QG
|
ADVIL 200MG TAB (GSK) IBUPROFEN
|
IBUPROFEN
|
ADVIL
|
24'S
|
C
|
8.18
|
0.34
|
TAB
|
120
|
BLIS
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
AVENTA BARBADOS
|
|
28080492
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
40
|
4141QH
|
ADVIL 200MG CAPLET (GSK/COL) IBUPROFEN
|
IBUPROFEN
|
ADVIL
|
24'S
|
C
|
7.42
|
0.31
|
CAPLET
|
0
|
CPL
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
28080492
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|